Vanguard Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.73M Sell
10,570,515
-581,390
-5% -$425K ﹤0.01% 3038
2025
Q1
$9M Sell
11,151,905
-2,471
-0% -$1.99K ﹤0.01% 2901
2024
Q4
$15.4M Sell
11,154,376
-156,306
-1% -$216K ﹤0.01% 2722
2024
Q3
$11.8M Buy
11,310,682
+708,293
+7% +$737K ﹤0.01% 2873
2024
Q2
$18.3M Buy
10,602,389
+522,835
+5% +$905K ﹤0.01% 2613
2024
Q1
$24.1M Sell
10,079,554
-277,858
-3% -$664K ﹤0.01% 2508
2023
Q4
$34.5M Buy
10,357,412
+575,285
+6% +$1.92M ﹤0.01% 2348
2023
Q3
$36.6M Buy
9,782,127
+932,476
+11% +$3.49M ﹤0.01% 2278
2023
Q2
$37.8M Buy
8,849,651
+2,992,451
+51% +$12.8M ﹤0.01% 2313
2023
Q1
$40.1M Buy
5,857,200
+41,318
+0.7% +$283K ﹤0.01% 2269
2022
Q4
$46.1M Buy
5,815,882
+587,181
+11% +$4.65M ﹤0.01% 2220
2022
Q3
$50.2M Buy
5,228,701
+345,286
+7% +$3.32M ﹤0.01% 2185
2022
Q2
$35.4M Buy
4,883,415
+146,314
+3% +$1.06M ﹤0.01% 2357
2022
Q1
$61.2M Buy
4,737,101
+189,572
+4% +$2.45M ﹤0.01% 2206
2021
Q4
$72.6M Buy
4,547,529
+33,228
+0.7% +$530K ﹤0.01% 2146
2021
Q3
$72.5M Buy
4,514,301
+38,697
+0.9% +$622K ﹤0.01% 2161
2021
Q2
$61.9M Buy
4,475,604
+214,504
+5% +$2.97M ﹤0.01% 2249
2021
Q1
$62.3M Buy
4,261,100
+132,165
+3% +$1.93M ﹤0.01% 2194
2020
Q4
$71.8M Buy
4,128,935
+262,406
+7% +$4.56M ﹤0.01% 2013
2020
Q3
$70.9M Buy
3,866,529
+76,467
+2% +$1.4M ﹤0.01% 1845
2020
Q2
$67.7M Buy
3,790,062
+663,453
+21% +$11.8M ﹤0.01% 1848
2020
Q1
$50.7M Buy
3,126,609
+47,906
+2% +$777K ﹤0.01% 1863
2019
Q4
$55.4M Buy
3,078,703
+150,309
+5% +$2.71M ﹤0.01% 2057
2019
Q3
$59.3M Sell
2,928,394
-30,189
-1% -$612K ﹤0.01% 1990
2019
Q2
$65.4M Buy
2,958,583
+87,091
+3% +$1.92M ﹤0.01% 1966
2019
Q1
$39.2M Buy
2,871,492
+105,380
+4% +$1.44M ﹤0.01% 2210
2018
Q4
$25M Buy
2,766,112
+83,311
+3% +$754K ﹤0.01% 2347
2018
Q3
$44.3M Buy
2,682,801
+406,520
+18% +$6.71M ﹤0.01% 2204
2018
Q2
$31.9M Buy
2,276,281
+213,759
+10% +$2.99M ﹤0.01% 2355
2018
Q1
$22.8M Buy
2,062,522
+182,074
+10% +$2.01M ﹤0.01% 2445
2017
Q4
$16.5M Sell
1,880,448
-587,118
-24% -$5.17M ﹤0.01% 2572
2017
Q3
$32.9M Buy
2,467,566
+212,099
+9% +$2.83M ﹤0.01% 2262
2017
Q2
$32.4M Buy
2,255,467
+46,223
+2% +$663K ﹤0.01% 2239
2017
Q1
$46.7M Buy
2,209,244
+1,039,402
+89% +$22M ﹤0.01% 2042
2016
Q4
$32.9M Buy
1,169,842
+140,141
+14% +$3.95M ﹤0.01% 2179
2016
Q3
$27.6M Buy
1,029,701
+21,403
+2% +$573K ﹤0.01% 2216
2016
Q2
$17M Buy
1,008,298
+352,103
+54% +$5.95M ﹤0.01% 2400
2016
Q1
$13.9M Buy
656,195
+40,576
+7% +$861K ﹤0.01% 2442
2015
Q4
$14.1M Buy
615,619
+19,012
+3% +$437K ﹤0.01% 2454
2015
Q3
$12M Buy
596,607
+66,950
+13% +$1.34M ﹤0.01% 2511
2015
Q2
$15.3M Buy
529,657
+354,114
+202% +$10.2M ﹤0.01% 2470
2015
Q1
$5.37M Buy
175,543
+103,861
+145% +$3.18M ﹤0.01% 2964
2014
Q4
$1.17M Buy
+71,682
New +$1.17M ﹤0.01% 3475